Data as of Apr 17
| +0.34 / +1.58%|
The 8 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 24.50, with a high estimate of 30.00 and a low estimate of 15.00. The median estimate represents a +12.28% increase from the last price of 21.82.
The current consensus among 11 polled investment analysts is to Hold stock in Meridian Bioscience Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.